How do you approach individualizing A1c goals in patients with dementia?

This is an important question for shared decision-making.

And it definitely is impacted by the severity/FAST staging of the dementia, as well as the class of medication use.

As we are all aware, we do not want to use the Sulfonylurea class in older adults, especially in patients with a dementia diag...

It's a question of time-to-benefit. As dementia typically has a 10-year life expectancy, with the later stages being functionally dependent, I often relax the Hgb A1c goal to 7.5-8%.

Other considerations are avoiding medications with risk for hypoglycemia, as noted in the above comment, while avoidi...